NetworkNewsBreaks – Endonovo Therapeutics Inc.
Post# of 416
Endonovo Therapeutics’ (OTCQB: ENDV) proprietary SofPulse(R) flagship device recently received a glowing review for minimizing pain from a foot-and-ankle specialist in Ohio who underwent tendon surgery. An article discussing the company reads, “In a homemade video, Dr. Jane Graenber, DPM, of the Foot and Ankle Wellness Center in Delaware, Ohio, attests that Endonovo’s SofPulse(R) electroceutical device has helped her to remain generally pain free a day after the tendon surgery, such that she says she has only used three doses of Tylenol for relief (no prescription pain pills) during the interim since her procedure (http://nnw.fm/KgYZ6). . . ‘This device is putting out a micro-current to my surgical area every two hours. . . . And it’s taken care of the pain, and I’m sitting here very comfortably,’ Graenber states in the video. ‘At our practice, we may be starting to include this postoperatively as an option to reduce pain. This was a pretty big surgery, and I’m really very comfortable. So I’m giving credit to a good surgeon but also a new device that may revolutionize pain (treatment) after surgery.’”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer